Page last updated: 2024-08-24

dexmedetomidine and baclofen

dexmedetomidine has been researched along with baclofen in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Heard, CM; Li, V; Morr, S; Reynolds, RM1
Bulloch, MN; Burry, L; Chan, C; Devabhakthuni, S; Dixit, D; Endicott, J; Ramos, L; Tobia, A; Yeung, SY1
Hardman, MI; Sprung, J; Weingarten, TN1
Laroche, JP1
Ahmed, S; Brewer, T; Defayette, A; Perrello, A; Picano, J1
Doi, M; Irifune, M; Kanematsu, T; Morioka, N; Mukai, A; Nakata, Y; Ogawa, Y; Oue, K; Sakai, N; Shimizu, Y; Yoshida, M1

Reviews

3 review(s) available for dexmedetomidine and baclofen

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients.
    Pharmacotherapy, 2016, Volume: 36, Issue:7

    Topics: Baclofen; Benzodiazepines; Critical Illness; Dexmedetomidine; Ethanol; Humans; Length of Stay; Phenobarbital; Substance Withdrawal Syndrome

2016
Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.
    Bosnian journal of basic medical sciences, 2019, May-20, Volume: 19, Issue:2

    Topics: Akathisia, Drug-Induced; Baclofen; Cyproheptadine; Dexmedetomidine; Diphenhydramine; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Haloperidol; Humans; Lorazepam; Male; Melatonin; Neuroleptic Malignant Syndrome; Olanzapine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult

2019

Other Studies

4 other study(ies) available for dexmedetomidine and baclofen

ArticleYear
Dexmedetomidine for acute baclofen withdrawal.
    Neurocritical care, 2015, Volume: 22, Issue:2

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Baclofen; Cerebral Palsy; Dexmedetomidine; GABA-B Receptor Agonists; Humans; Male; Quadriplegia; Substance Withdrawal Syndrome

2015
Subcutaneous dexmedetomidine for baclofen withdrawal during palliative sedation.
    BMJ supportive & palliative care, 2020, Volume: 10, Issue:1

    Topics: Baclofen; Dexmedetomidine; Humans; Hypnotics and Sedatives; Infusions, Subcutaneous; Male; Middle Aged; Palliative Care; Substance Withdrawal Syndrome

2020
Enteral baclofen withdrawal managed with intravenous dexmedetomidine: A case report.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020, Feb-19, Volume: 77, Issue:5

    Topics: Back Pain; Baclofen; Chronic Pain; Dexmedetomidine; Dose-Response Relationship, Drug; GABA-B Receptor Agonists; Humans; Hypnotics and Sedatives; Male; Middle Aged; Substance Withdrawal Syndrome

2020
The indirect γ-aminobutyric acid (GABA) receptor agonist gabaculine-induced loss of the righting reflex may inhibit the descending analgesic pathway.
    Pharmacology, biochemistry, and behavior, 2020, Volume: 198

    Topics: Adrenergic alpha-2 Receptor Agonists; Analgesics; Animals; Baclofen; Cyclohexanecarboxylic Acids; Dexmedetomidine; GABA Agonists; Ganglia, Spinal; Male; Mice; Morphine; Muscimol; Neural Pathways; Neurons; Pain Measurement; Rats; Reflex, Righting; Signal Transduction; Spinal Cord; Substance P

2020